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Background: Disrupted HCO3
– transport and reduced airway surface liquid (ASL) pH in cystic ﬁbrosis (CF) may initiate airway disease. We
hypothesized that ASL pH is reduced in neonates with CF.
Methods: In neonates with and without CF, we measured pH of nasal ASL. We also measured nasal pH in older children and adults.
Results: In neonates with CF, nasal ASL (pH 5.2 ± 0.3) was more acidic than in non-CF neonates (pH 6.4 ± 0.2). In contrast, nasal pH of CF
children and adults was similar to values measured in people without CF.
Conclusions: At an age when infection, inﬂammation and airway wall remodeling are minimal, neonates with CF had an acidic nasal ASL
compared to babies without CF. The CF:non-CF pH difference disappeared in older individuals, perhaps because secondary manifestations of
disease increase ASL pH. These results aid understanding of CF pathogenesis and suggest opportunities for therapeutic intervention and
monitoring of disease.
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,lishedterized by bacterial infection and inflammation remains the
major cause of morbidity and mortality.
CFTR channels conduct both Cl− and HCO3
– [3]. Several
observations suggest that reduced HCO3
– transport may be a
key factor in the pathogenesis of CF airway disease. First, loss
of CFTR impairs HCO3
– secretion across airway epithelia
cultured from humans [4,5] and pigs with a disrupted CFTR
gene [6]; CF pigs spontaneously develop lung disease that
mimics human CF [7]. Second, loss of CFTR reduces the pH of
airway surface liquid (ASL) in cultured human airway epithelia
[5], of secretions from human submucosal glands studied ex
vivo [8], and of ASL studied in vivo, ex vivo, and in epithelial
cultures from CF pigs [9]. Third, a reduced pH decreases the
activity of antimicrobials in ASL in vivo and in vitro, therebyby Elsevier B.V. All rights reserved.
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Fig. 1. Nasal ASL pH. A. pH of nasal ASL in healthy volunteers (n = 5) before
and after aerosol administration of a 5% NaHCO3 or 5% NaCl solutions. Data are
mean ± SEM; some error bars are hidden by symbols. B. Nasal pH in non-CF
(white, n = 23) and CF (dark gray, n = 7) neonates, children (n = 11 non-CF and
n = 14 CF), and adults (n = 10 non-CF and n = 10 CF). Data points are values
for individuals, bars are means ± SEM. * p b0.01 (Student's t test). C. Nasal pH
in neonates with no CFTR mutations (n = 4), neonates heterozygous for a CFTR
mutation (n = 19) and neonates with CF (n = 7). * p b0.01 (one-way ANOVA,
Bonferroni's multiple comparisons test).
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[9]. Fourth, a reduced pH may alter the properties of mucus
secreted into the airways and thereby hinder mucociliary
transport [10].
However, an earlier study reported that there was no CF:
non-CF difference in ASL pH measured in vivo in humans [11].
That result contrasts with the observation that airway pH is
reduced in the ASL of CF pigs studied within 24 h of birth [9].
That discrepancy might be due to differences in the state of the
airways because the humans with CF were studied as adults or
older children, a time when airway disease is present [11]. In
contrast, newborn CF pigs lack airway infection, inflammation,
goblet cell hyperplasia and submucosal gland hypertrophy [7].
Therefore, we hypothesized that like newborn CF pigs, ASL
in human neonates with CF would have a reduced pH compared
to neonates without CF. To test this hypothesis, we measured
the pH of nasal ASL because doing so is a non-invasive
procedure and because transepithelial electrolyte transport in
nasal and tracheal/bronchial epithelia has substantial similarity
[11–14]. We studied neonates in an attempt to minimize the
potential confounding effects of infection and inflammation.We
also measured nasal pH in older children and adults.
2. Methods
All newborns in Iowa undergo a dried blood spot test, to
screen for several genetic diseases including CF. An immuno-
reactive trypsinogen (IRT) ≥65 ng/ml is considered a positive
screening test for CF [15]. During the period from April 2012
until August 2013, we enrolled neonates with a positive CF
screen, older children and adults with CF (ages 3 mos. to
60 yrs.), and healthy volunteers. Children and adults with
concomitant nasal or paranasal sinus complaints or history of
upper respiratory tract infections in the preceding 3 weeks were
excluded from study. All studies were approved by the
University of Iowa institutional review board (IRB). Informed
consent was obtained from the subjects or their legally
authorized representative.
The parents of 31 neonates consented to participate in the
study. We excluded one neonate with an IRT 99, sweat Cl− 7/9
and genotype F508C/3120 + 1G N A. The F508C mutation has
been reported either as benign with normal clinical and
epithelial physiological studies in two healthy subjects with
F508del/F508C mutations [16], or as disease-causing in one
subject with typical symptoms of CF and pancreatic insuffi-
ciency carrying F508C/unknown mutations [17]. This neonate
had a nasal ASL pH of 4.1. Adding this subject to either the CF
or the non-CF groups did not change the conclusions.
We used a Sandhill ZepHr PHNS-P (Sandhill Scientific,
Highlands Ranch, CO) Mobidium pH probe with an internal
reference electrode. Prior to each study, the pH probe was
calibrated in buffer solutions of pH 6, 7 and 8 (VWR, West
Chester, PA). Voltage was recorded with an Oakton pH6+
meter (Cole-Parmer, Vernon Hills, IL) and corrected to
temperature. The probe was positioned 6 cm (adults), 1.5 cm
(children) and 1.0 cm (neonates) from the most caudal aspect
of the columella (Supplemental Figure S1). The catheterremained in position until the reading was stable for 15 s. All
measurements were taken by the same operator. In neonates,
the operator was blinded to diagnosis and measurements were
obtained within 3 months after birth.
NaHCO3 or NaCl were prepared as 5% solutions and
administered intra-nasally at the same time to opposite nostrils
using a 250 μl preloaded Accuspray syringe (Becton Dickinson
Pharmaceutical Systems, Franklin Lakes, NJ) [18].3. Statistical analyses
Statistical significance was evaluated by Student's t test. For
subgroups analysis in Fig. 1C, we used one-way ANOVA with
Bonferroni's multiple comparisons test.
Table 1
Clinical characteristics of neonates.
Subject Age Sex Mutation 1 Mutation 2 Sweat Cl− IRT pH
Non-CF 19 d F None None 10/12 66 5.3
Non-CF 29 d F None None 11/8 178 7.3
Non-CF 20 d M None None 17/14 189 6.1
Non-CF 23 d M None None 13/18 250 7.4
Het 20 d F F508del None 20/22 72 6.5
Het 29 d M R553X None 5/10 81 5.5
Het 22 d M F508del None 11/13 75 6.7
Het 22 d M F508del None 11/12 69 7.9
Het 19 d M F508del None 11/19 72 7.4
Het 33 d F F508del None 6/7 64 5.0
Het 26 d M N1303K None 7/13 70 5.4
Het 13 d F G551D None 7/8 148 4.5
Het 79 d F F508del None 5/5 68 4.9
Het 9 d M F508del None 40/33 65 6.5
Het 27 d F F508del None 13/12 94 6.9
Het 35 d M F508del None 15/11 115 6.8
Het 28 d F R553X None 8/9 88 7.8
Het 34 d M F508del None 10/10 74 7.1
Het 23 d F F508del None 8/13 69 7.2
Het 14 d F F508del None 9/9 81 6.0
Het 22 d F F508del None 5/5 67 6.7
Het 23 d F F508del None 5/6 83 6.0
Het 12 d F F508del None 5/9 67 7.1
CF 13 d F F508del F508del 66/89 231 4.5
CF 13 d M F508del G542X 95/99 87 4.8
CF 9 d M G542X N1303K 91/95 166 4.8
CF 21 d M R668C, G576A, D443Y F508del 41/44 65 4.8
CF 15 d M F508del G551D 75/81 195 6.3
CF 44 d F F508del G542X 69/70 423 5.9
CF 13 d F F508del F508del 32/– 132 5.7
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As a test of the pH assay, we applied NaHCO3 as an aerosol
spray to the nasal surface and measured pH in 5 healthy adults.
Administering 5% NaHCO3 immediately and transiently
alkalinized ASL pH, whereas 5% NaCl had little effect
(Fig. 1A). Additional experiments demonstrated concordance
of measurements between right and left nostrils, and reproduc-
ibility of the assay (Supplemental Figures S2, and S3).
To recruit neonates, we evaluated babies with a positive
screening test for CF. Newborns in Iowa are screened by
measuring blood IRT; those with a positive test are referred for
additional testing. A fraction of those infants will receive a
diagnosis of CF. Thus, this population yielded babies with CF as
well as non-CF babies who served as age-matched controls. We
studied infants before results of their genetic tests or sweat tests
were known. Thus, operators were unaware of the diagnosis.
We measured nasal pH 24 ± 2 days (range, 9–79 days)
after birth. Table 1 shows the genotypes and demographics of 7
babies with CF and 23 without CF. In CF neonates, the nasal
pH of 5.2 ± 0.3 was more acidic than the pH of 6.4 ± 0.2 in
non-CF neonates (Fig. 1B).
Because a previous study of older subjects did not detect a
CF:non-CF difference [11], we measured nasal pH in people
with CF beyond the neonatal period (Table 2). In contrast to our
findings in neonates, the nasal pH of CF children and adults
was similar to values measured in people without CF (Fig. 1B).Our cohort of children and adults with CF included subjects
with mutations known to exhibit partial CFTR activity
(Table 2). Excluding these subjects from the analysis did not
affect the results.
In a separate analysis, we tested whether neonates hetero-
zygous for a CF-associated mutation had a reduced nasal pH
and found that their pH (pH = 6.4 ± 0.2, n = 19) did not
statistically differ from that in neonates with no CFTR
mutations (pH = 6.5 ± 0.5, n = 4). However, our ability to
detect a difference between heterozygotes and neonates with no
CFTR mutations was limited by the small number of babies.
The nasal pH of heterozygous neonates was higher than that in
neonates with two CFTR mutations (Fig. 1C).
5. Discussion
Data from this small, single center pilot study suggest that
neonates with CF have an acidic nasal ASL compared to babies
without CF. Although infection, inflammation and airway wall
remodeling begin soon after birth, obtaining measurements in
neonates should minimize the effect of those disease conse-
quences on ASL pH. We also found that the CF:non-CF
difference disappeared in older individuals.
Our results emphasize a distinction between airways not
affected by infection, inflammation and remodeling and
airways studied later in the course of disease. In cultured
human and porcine airway epithelia, ASL pH was lower in CF
Table 2
Clinical characteristics of children (age 3 mos. to 12 yrs.) and adults (age 21 yrs. to 58 yrs.) with CF.
Age Sex Mutation 1 Mutation 2 Sweat Cl− FEV1 %FEV1 Col pH
3 m F F508del p.1336 K 85/81 – – N 6.13
4 m M F508del F508del 85/89 – – N 6.43
7 m F F508del G542X 94/88 – – S 6.84
9 m F F508del 1973_1985del13insAGAAA 102/97 – – N 6.12
2 y F F508del F508del 99/115 – – S, P 5.94
2 y M F508del F508del 95/94 – – S, P 6.58
3 y F F508del R117H 24/29 – – P 6.43 a
3 y M F508del F508del 89/83 – – S, P 5.94
3 y M F508del F508del 67/56 – – S 6.90
6 y F F508del S549N 78/82 – – S, P 6.96
6 y F G542X 1717G N A 116/118 – – S, P 5.92
11 y M F508del 1154insTC 130/131 – – S, P 5.42
11 y M F508del F508del 101/103 – – S, P 6.14
12 y F R64Q, R297Q Y109N 39/49 – – S 5.00 a
21 y F F508del F508del 98/107 3.01 100 S, P 6.88
23 y F F508del F508del 70/65 1.86 56 S, P 7.20
28 y M F508del F508del 81/94 1.15 28 S, P 7.02
30 y M F508del F508del 74/53 2.64 94 P 6.10
30 y F F508del F508del 70/83 2.88 83 S, P 7.42
40 y M F508del F508del 80/113 3.84 82 P 6.49
46 y M F508del R347H 73/79 1.55 36 P 6.34
47 y F D1152H F508del – 2.76 95 N 8.10 a
56 y M F508del G551D 139/141 2.14 61 P 5.00
58 y F F508del 3849 + 10 46/44 2.76 76 P 5.84 a
col = colonization, S = S. aureus, P = P. aeruginosa, N = no bacteria detected
a mutations with known partial CFTR activity
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was identical for both genotypes. For CF pigs studied the day
they are born and before infection and inflammation in vivo and
ex vivo assays showed that CF pigs have an abnormally acidic
pH [9]. A study of submucosal gland secretions from nasal
tissue of people with CF undergoing sinus surgery also
revealed an acidic ASL pH [8]. These findings contrast with
two other studies of airways likely to be involved by secondary
consequences of the disease. The pH of submucosal gland
secretions from CF airways removed at the time of lung
transplantation did not differ from non-CF [19]. In addition, a
study of adults with CF and pediatric patients with CF
(3–16 years old) observed no CF:non-CF difference in ASL
pH [11]. Thus, our data in neonates and older people are
consistent with earlier studies, and together they suggest that
infection, inflammation, airway remodeling and/or other factors
minimize CF:non-CF differences in ASL pH.
Our data do not reveal the mechanisms that might eliminate
the pH differences with time. Developmental changes in the
mechanisms that control ASL pH are possible. However, earlier
studies in non-CF people showed that inflammation increased
ASL pH [20,21]. Furthermore, measuring exhaled breath
condensate pH in CF patients showed no difference from
control group when the confounding effect of exhaled CO2 on
pH was taken into account [22–24]. We speculate that ASL pH
increased in CF airways because inflammation altered pH
regulatory mechanisms, whereas in the absence of inflamma-
tion, non-CF ASL pH was unaltered.
Additional larger studies will be required to validate these
findings. If they do, the results have important implications.First, they suggest that reduced ASL pH may be a key
abnormality that initiates airway disease. Second, it is possible
that ASL pH becomes a less important pathogenic factor as
disease progresses. Perhaps at that time, other factors become
more important in fueling disease progression. Third, normal-
izing ASL pH in infants may be a therapeutic strategy and
measurements of ASL pH might report on the success of
therapeutic interventions.Conﬂict of interest statement
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